Scopus:
Evaluation of subclinical retinopathy and angiopathy with OCT and OCTA in patients with systemic lupus erythematosus

dc.contributor.authorIşık M.U.
dc.contributor.authorAkmaz B.
dc.contributor.authorAkay F.
dc.contributor.authorGüven Y.Z.
dc.contributor.authorSolmaz D.
dc.contributor.authorGercik Ö.
dc.contributor.authorKabadayı G.
dc.contributor.authorKurut İ.
dc.contributor.authorAkar S.
dc.date.accessioned2023-04-12T01:01:15Z
dc.date.available2023-04-12T01:01:15Z
dc.date.issued2021-01-01
dc.description.abstractPurpose: To evaluate the choroidal and retinal layers with optical coherence tomography (OCT) and retinal microvascular structures with optical coherence tomography angiography (OCTA) in systemic lupus erythematosus (SLE) patients. Method: In this prospective, cross-sectional and comparative study, a total of 35 SLE patients and 35 healthy control participants were included. SLE patients who were using hydroxychloroquine (HCQ) and/or immunosuppressive agents are evaluated with OCT and OCTA. SLE patients who have no HCQ maculopathy observed in OCT were included in the patient group. Results: Mean macular thickness and ganglion cell inner plexiform layer (GC-IPL) thicknesses were thinner in the patient group. When the parameters obtained with OCTA were evaluated, vessel (VD) and perfusion density (PD) were significantly lower in the patient group. Central foveal thickness and foveal avascular zone parameters were negatively correlated. In addition, VD and PD, and GC-IPL thicknesses were positively correlated. Conclusion: Application of OCTA for the evaluation of microvasculature in SLE patients may be useful in subclinical changes.
dc.identifier.doi10.1007/s10792-020-01561-8
dc.identifier.issn01655701
dc.identifier.pubmed32851556
dc.identifier.scopus2-s2.0-85089863869
dc.identifier.urihttps://hdl.handle.net/20.500.12597/4622
dc.relation.ispartofInternational Ophthalmology
dc.rightsfalse
dc.subjectHydroxychloroquine | Optical coherence tomography | Optical coherence tomography angiography | Subclinical retinal changes | Systemic lupus erythematosus
dc.titleEvaluation of subclinical retinopathy and angiopathy with OCT and OCTA in patients with systemic lupus erythematosus
dc.typeArticle
dspace.entity.typeScopus
oaire.citation.issue1
oaire.citation.volume41
person.affiliation.nameKastamonu University
person.affiliation.nameİzmir Kâtip Çelebi Üniversitesi
person.affiliation.nameİzmir Kâtip Çelebi Üniversitesi
person.affiliation.nameİzmir Kâtip Çelebi Üniversitesi
person.affiliation.nameİzmir Kâtip Çelebi Üniversitesi
person.affiliation.nameİzmir Kâtip Çelebi Üniversitesi
person.affiliation.nameİzmir Kâtip Çelebi Üniversitesi
person.affiliation.nameİzmir Kâtip Çelebi Üniversitesi
person.affiliation.nameİzmir Kâtip Çelebi Üniversitesi
person.identifier.orcid0000-0001-7337-5469
person.identifier.scopus-author-id57205127949
person.identifier.scopus-author-id56011145100
person.identifier.scopus-author-id24066325300
person.identifier.scopus-author-id57210966775
person.identifier.scopus-author-id57208486786
person.identifier.scopus-author-id57203268752
person.identifier.scopus-author-id57198776673
person.identifier.scopus-author-id57216530638
person.identifier.scopus-author-id7004438602
relation.isPublicationOfScopusef6cb8a8-155e-490d-b9d6-d811365cf135
relation.isPublicationOfScopus.latestForDiscoveryef6cb8a8-155e-490d-b9d6-d811365cf135

Files